EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Colchicine inhibits macrophage motility and matrix degradation through microtubule disruption

Mansi Vansjariya, Aaron L Magno, Fiona J Pixley, Carl J Schultz, Julie M Proudfoot

Vascular Pharmacology · 2026

DOI: 10.1016/j.vph.2026.107587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular Pharmacology, 2026. Verfasst von Mansi Vansjariya und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia. Hauptthemen laut MEDLINE: Colchicine, Microtubules, Cell Movement, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Western Australia, Royal Perth Hospital Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atherosclerosis is a chronic inflammatory process wherein macrophages play a central role in the evolution of arterial wall plaques in extracellular matrix. Colchicine, a drug used most commonly to treat gout, reduces immune cell motility and recruitment to inflamed joints by targeting microtubules. Colchicine also reduces cardiovascular events in patients with recent acute or chronic coronary disease, but the mechanisms are incompletely understood. AIMS: To characterise the effect of low-dose colchicine on human and mouse macrophages, focusing on the microtubule cytoskeleton and macrophage function. METHODS: Human monocytes were isolated from buffy coats and differentiated into macrophages (huMDM) in culture medium. Mouse bone marrow-derived macrophages (msBMM) were extracted from C57BL/6 mice and grown in culture medium to produce mature adherent macrophages. RESULTS: HuMDM treated with 10 nM colchicine showed marked morphological and functional changes associated with disruption of the microtubule cytoskeleton. Colchicine reduced the footprint area of huMDM by almost 50% and matrix degradation by 20%. In contrast, colchicine minimally affected the morphology of msBMM. However, it reduced the density of the microtubule cytoskeleton at the leading edge of msBMM with detectable disruption of microtubules, resulting in a significant decrease in motility. CONCLUSIONS: While msBMM appeared less susceptible to low-dose colchicine than huMDM, there was a measurable effect on their microtubules that resulted in reduced motility. Inhibition of huMDM matrix degradative capacity may contribute to colchicine's effect in reducing cardiovascular events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineMicrotubulesCell MovementMacrophagesTubulin ModulatorsExtracellular MatrixAnimalsHumansMice, Inbred C57BLCells, CulturedMice

Stichwörter der Autor:innen

AtherosclerosisColchicineCytoskeletonMacrophageMicrotubules

Substanzen

ColchicineTubulin Modulators

Autor:innen und Institutionen

  • School of Biomedical Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.
  • Research Centre, Royal Perth Hospital, Victoria Square, Perth, WA 6000, Australia.
  • School of Biomedical Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia. Electronic address: fiona.pixley@uwa.edu.au.
  • Medical School, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia; Department of Cardiology, Royal Perth Hospital, Victoria Square, Perth, WA 6000, Australia. Electronic address: carl…
  • Medical School, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia; School of Biomedical Sciences - Royal Perth Hospital Unit, The University of Western Australia, 35 Stirling Highway,…

Förderung

  • University of Western Australia
  • Royal Perth Hospital Medical Research Foundation

Zitieren

APA

Vansjariya, M., Magno, A. L., Pixley, F. J., Schultz, C. J., & Proudfoot, J. M. (2026). Colchicine inhibits macrophage motility and matrix degradation through microtubule disruption. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2026.107587

Vancouver

Vansjariya M, Magno AL, Pixley FJ, Schultz CJ, Proudfoot JM. Colchicine inhibits macrophage motility and matrix degradation through microtubule disruption. Vascular Pharmacology. 2026. doi:10.1016/j.vph.2026.107587

BibTeX
@article{Vansjariya2026,
  author = {Vansjariya, Mansi and Magno, Aaron L and Pixley, Fiona J and Schultz, Carl J and Proudfoot, Julie M},
  title = {Colchicine inhibits macrophage motility and matrix degradation through microtubule disruption},
  journal = {Vascular Pharmacology},
  year = {2026},
  doi = {10.1016/j.vph.2026.107587}
}
Kostenlos starten →